Menu

Inhibrx Biosciences, Inc. INBX

Full chart Compare
Set alert

Price alert · INBX

All alert types
84.52 USD +4.24 (+5.28%)

At closeNov 6, 2026, 7:29 PM EST

82.41 -2.11 -2.50%

After hours · Nov 6, 7:29 PM ET

79.47 Day range 85.57
58.39 52-week range 141.84
YTD
+6.99%
1 year
+4.36%

Revenue & Expenses

Other Operating Income → Expenses: $2.48MExpenses → Gross Loss: $1.18MExpenses → Selling, General & Admin: $23.30MExpenses → Research & Development: $113.03MExpenses → Other Expenses: $5.03MExpenses → Income Tax: $2.00KNet Loss → Expenses: $140.06MRevenue → Cost of Revenue: $1.30MOther Operating Income$2.48MNet Loss$140.06MCost of Revenue$2.48MExpenses$142.54MGross Loss$1.18MSelling, General & Admin$23.30MResearch & Development$113.03MOther Expenses$5.03MIncome Tax$2.00KRevenue$1.30M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

INBX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.30M200.00K1.80M2.19M7.23M
1.30M200.00K1.80M2.19M7.23M
1.30M200.00K1.80M2.19M7.23M
136.32M331.65M221.02M131.31M83.80M
113.03M203.74M191.64M110.19M71.44M
23.30M127.91M29.38M21.12M12.36M
-135.03M-331.45M-219.22M-129.12M-76.56M
12.20M13.49M31.84M18.18M5.22M
2.00K2.00K3.00K3.00K2.00K
-140.06M1.69B-241.36M-145.23M-81.77M
-140.06M1.69B-241.36M-145.23M-81.77M
-140.06M1.69B-241.36M-145.23M-81.77M
-140.06M1.69B-241.36M-145.23M-81.77M
-9.04114.01-20.48-3.62-2.15
-9.04114.01-20.48-3.62-2.15
-9.04112.62-20.48-3.62-2.15
-127.86M1.70B-209.52M-127.04M-76.55M
-127.86M1.70B-209.52M-127.04M-76.55M
15.49M14.80M11.78M40.11M38.01M
15.49M14.98M11.78M40.11M38.01M